2006
DOI: 10.1002/ana.20861
|View full text |Cite
|
Sign up to set email alerts
|

Slow‐channel mutation in acetylcholine receptor αM4 domain and its efficient knockdown

Abstract: alphaC418W occurring in humans causes a slow-channel syndrome by enhancing the relative stability of the channel open state. Efficient and selective knockdown of the mutant allele holds promise of therapeutic gene silencing.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
43
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 45 publications
(45 citation statements)
references
References 47 publications
2
43
0
Order By: Relevance
“…Slow channel congenital myasthenia syndromes (SCCMS) are a group of genetic disorders of neuromuscular transmission characterized by a progressive degeneration of the neuromuscular junction and muscle atrophy leading to fatigability and weakness. The novel SCCMS nAChR mutant ␣C418W is the first lipid-exposed mutation identified in a patient (7).…”
mentioning
confidence: 99%
“…Slow channel congenital myasthenia syndromes (SCCMS) are a group of genetic disorders of neuromuscular transmission characterized by a progressive degeneration of the neuromuscular junction and muscle atrophy leading to fatigability and weakness. The novel SCCMS nAChR mutant ␣C418W is the first lipid-exposed mutation identified in a patient (7).…”
mentioning
confidence: 99%
“…Side chains of residues forming part of the agonist-binding site (αTrp149) and the channel gate (αLeu251, as well as analogous β-, γ-and δ-subunit leucines) are shown in blue and tan, respectively. A Cys residue at the lipid-protein interface of α-TM4, whose mutation to Trp in the muscle-type nAChR leads to biological consequences (Shen et al 2006), is highlighted in yellow. Views from the synaptic cleft are shown on the right for the agonist-binding (top) and transmembrane pore domains (bottom) with color coding to highlight the different subunits (α, red; β, blue; γ, purple, and δ, green)…”
Section: The M4 Lipid-sensor Modelmentioning
confidence: 99%
“…humans (Shen et al 2006). The non-competitive antagonist, promegestone likely interacts at the interface between M4 and M1+M3 (Blanton et al 1999).…”
Section: The M4 Lipid-sensor Modelmentioning
confidence: 99%
See 1 more Smart Citation
“…lipid-protein interactions at the WHc interface, because of existing knowledge of channel structure, gating mechanics and the overall spatial orientation of the lipid exposed domains. [21][22][23][24][25][26][27] We introduced a series of amino acid substitutions by site-directed mutagenesis at the position phenylalanine 426 (F426) in the M4 domain of the alpha subunit ( Figs. 1 and 2).…”
Section: Introductionmentioning
confidence: 99%